Building on the link between annexin A1 and basal-like breast cancers that was described by de Graauw et al, we have demonstrated that high expression of annexin A1 has functional implications and is associated with shorter survival in basal-like breast cancer patients. Here, ANXA1 is linked to breast carcinoma.